Literature DB >> 26511997

Remission in SLE: closing in on the target.

Ronald F van Vollenhoven1, Alexandre Voskuyl2, Eric Morand3, Cynthia Aranow4.   

Abstract

Entities:  

Keywords:  Outcomes research; Systemic Lupus Erythematosus; Treatment

Mesh：

Year:  2015        PMID： 26511997     DOI： 10.1136/annrheumdis-2015-208231

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort.

Authors:  Vera Golder; Rangi Kandane-Rathnayake; Alberta Yik-Bun Hoi; Molla Huq; Worawit Louthrenoo; Yuan An; Zhan Guo Li; Shue Fen Luo; Sargunan Sockalingam; Chak Sing Lau; Alfred Lok Lee; Mo Yin Mok; Aisha Lateef; Kate Franklyn; Susan Morton; Sandra Teresa V Navarra; Leonid Zamora; Yeong-Jian Wu; Laniyati Hamijoyo; Madelynn Chan; Sean O'Neill; Fiona Goldblatt; Eric Francis Morand; Mandana Nikpour
Journal:  Arthritis Res Ther       Date:  2016-11-09       Impact factor: 5.156

2.  Immunosuppressive Treatment for Lupus Nephritis: Long-Term Results in 178 Patients.

Authors:  Elena V Zakharova; Tatiana A Makarova; Elena V Zvonova; Alina M Anilina; Ekaterina S Stolyarevich
Journal:  Biomed Res Int       Date:  2016-12-05       Impact factor: 3.411

3.  Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey.

Authors:  Pintip Ngamjanyaporn; Eoghan M McCarthy; Jamie C Sergeant; John Reynolds; Sarah Skeoch; Benjamin Parker; Ian N Bruce
Journal:  Lupus Sci Med       Date:  2017-06-29

4.  Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study.

Authors:  Eric F Morand; David A Isenberg; Daniel J Wallace; Amy H Kao; Cristina Vazquez-Mateo; Peter Chang; Kishore Pudota; Cynthia Aranow; Joan T Merrill
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

5.  Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis.

Authors:  Shiyuan Qiu; Hengci Zhang; Sijie Yu; Qin Yang; Gaofu Zhang; Haiping Yang; Qiu Li; Mo Wang
Journal:  Pediatr Nephrol       Date:  2021-08-11       Impact factor: 3.714

6.  Metabolomics Defines Complex Patterns of Dyslipidaemia in Juvenile-SLE Patients Associated with Inflammation and Potential Cardiovascular Disease Risk.

Authors:  George A Robinson; Junjie Peng; Ines Pineda-Torra; Coziana Ciurtin; Elizabeth C Jury
Journal:  Metabolites       Date:  2021-12-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.